Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Oct 16, 2020
Product Development

Recent Phase III disappointment aside, the heart failure pipeline holds plenty to look forward to

Drug development for heart failure is picking up, with five clinical readouts from five mechansims expected in the next year
BioCentury | Mar 15, 2017
Distillery Techniques

Biomarkers

BioCentury | Jan 18, 2017
Translation in Brief

Keep a cool head

Neuro Pharmalogics is exploiting insect biology for orphan neurological diseases
BioCentury | Sep 1, 2011
Distillery Therapeutics

Indication: Neurology

BioCentury | Jun 11, 2009
Distillery Therapeutics

Indication: Cardiovascular disease

Items per page:
1 - 5 of 5